Table 1.

Sample characteristics^*

Characteristic	Placebo (n = 70)	ABM (n = 64)	F	p value†
Age, yr	39.65 ± 13.54	39.09 ± 12.80	0.061	0.81
Female, no.	44	47	1.717	0.20
Education level, ISCED	5.92 ± 1.20	5.85 ± 1.27	0.113	0.74
SSRI medication, no.‡	23	22	0.035	0.86
No. of major depressive episodes§	4.48 ± 5.30	4.79 ± 7.56	0.077	0.78
Days between ABM and fMRI	6.94 ± 8.70	6.65 ± 7.19	0.041	0.84
Baseline symptoms
Hamilton Rating Scale for Depression	7.53 ± 4.69	9.56 ± 6.38	4.469	0.036
Beck Depression Inventory II	12.09 ± 8.66	17.12 ± 11.62	8.187	0.005

ABM = attentional bias modification; fMRI = functional MRI; ISCED = International Standard Classification of Education; SSRI = selective serotonin reuptake inhibitor.

^*Unless otherwise indicated, findings are presented as mean ± standard deviation.

^†Pearson χ² test for dichotomous variables.

^‡Any current use of an antidepressant belonging to the SSRI class.

^§According to the MINI International Neuropsychiatric Interview.